Keppra

In the US, Keppra (levetiracetam systemic) is a member of the drug class pyrrolidine anticonvulsants and is used to treat Bipolar Disorder, Epilepsy, Neuralgia, New Daily Persistent Headache and Seizures.

US matches:

• Keppra


• Keppra Solution


• Keppra Tablets


• Keppra XR Extended-Release Tablets


• Keppra XR


• Keppra Intravenous


• Keppra Injection


• Keppra-XR

UK matches:

• Keppra (SPC)
• Keppra 250,500,750 and 1000 mg film-coated Tablets, 100 mg/ml oral solution and 100 mg/ml concentrate for solution for infusion (SPC)
• Keppra film-coated Tablets 250mg, 500mg, 750mg, 1000mg, Keppra 100mg/ml oral solution, Keppra 100mg/ml concentrate for solution for infusion (SPC)

Ingredient matches for Keppra

Levetiracetam

Levetiracetam is reported as an ingredient of Keppra in the following countries:

• Australia


• Austria


• Bahrain


• Belgium


• Benin


• Bulgaria


• Burkina Faso


• Canada


• Central African Republic


• Chad


• Colombia


• Congo


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Finland


• France


• Gabon


• Germany


• Greece


• Guinea


• Hong Kong


• Hungary


• Indonesia


• Ireland


• Israel


• Italy


• Luxembourg


• Madagascar


• Malaysia


• Mali


• Mauritania


• Mauritius


• Mexico


• Netherlands


• New Zealand


• Niger


• Norway


• Oman


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Togo


• Turkey


• United Kingdom


• United States


• Vietnam


• Zaire

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.